Technical Report abstract


Nature Medicine 14, 213 - 221 (2008)
Published online: 13 January 2008 | doi:10.1038/nm1684

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

Harald C Ott1, Thomas S Matthiesen2, Saik-Kia Goh2, Lauren D Black3, Stefan M Kren2, Theoden I Netoff3 & Doris A Taylor2,4

Top

About 3,000 individuals in the United States are awaiting a donor heart; worldwide, 22 million individuals are living with heart failure. A bioartificial heart is a theoretical alternative to transplantation or mechanical left ventricular support. Generating a bioartificial heart requires engineering of cardiac architecture, appropriate cellular constituents and pump function. We decellularized hearts by coronary perfusion with detergents, preserved the underlying extracellular matrix, and produced an acellular, perfusable vascular architecture, competent acellular valves and intact chamber geometry. To mimic cardiac cell composition, we reseeded these constructs with cardiac or endothelial cells. To establish function, we maintained eight constructs for up to 28 d by coronary perfusion in a bioreactor that simulated cardiac physiology. By day 4, we observed macroscopic contractions. By day 8, under physiological load and electrical stimulation, constructs could generate pump function (equivalent to about 2% of adult or 25% of 16-week fetal heart function) in a modified working heart preparation.

Top
  1. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA.
  2. Center for Cardiovascular Repair, University of Minnesota, 312 Church Street Southeast, 7-105A NHH, Minneapolis, Minnesota 55455, USA.
  3. Department of Biomedical Engineering, University of Minnesota, 312 Church Street Southeast, 7 NHH, Minneapolis, Minnesota 55455, USA.
  4. Department of Integrative Biology and Physiology, University of Minnesota, 6-125 Jackson Hall, 312 Church Street Southeast, Minneapolis, Minnesota 55455, USA.

Correspondence to: Doris A Taylor2,4 e-mail: dataylor@umn.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Research highlights

Nature Biotechnology News and Views (01 Feb 2008)

RESEARCH

Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection

Journal of Cerebral Blood Flow & Metabolism Original Article

Supplementary Information

Nature Materials Article (01 Dec 2008)

Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo

Nature Medicine Article (01 Sep 2001)


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

  • Fast Growth of Transformed Soybean Shoots

    • Deadline: Jul 15 2009
    • Reward: $10,000 USD

    A method for accelerating growth of soybean shoots is desired.

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

  • Postdoc in cancer research

    • Penn State University
    • Hershey, PA, USA 17033
  • Postdoctoral Position

    • McGill University
    • Goodman Cancer Centre, McGill University, Cancer Pavilion, 1160 Pine Avenue West, Room 414, Montreal, Quebec , Canada, H3A 1A3

natureproducts


ADVERTISEMENT